AstraZeneca (Distribution rights of Foscavir) Overview
- Status
- Acquired/Merged
- Latest Deal Type
- Asset Purch.
- Financing Rounds
- 1
AstraZeneca (Distribution rights of Foscavir) General Information
Description
The global marketing and distribution rights of antiviral agent. The antiviral agent is licensed for the treatment of cytomegalovirus (CMV) retinitis in HIV patients and acyclovir-resistant mucocutaneous herpes simplex virus (HSV) infections in immunocompromised patients.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Other Commercial Services
Pharmaceuticals
Acquirer
Primary Office
- 2 Kingdom Street
- London W2 6BD
- England, United Kingdom
AstraZeneca (Distribution rights of Foscavir) Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore AstraZeneca (Distribution rights of Foscavir)‘s full profile, request access.
Request a free trialAstraZeneca (Distribution rights of Foscavir) Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore AstraZeneca (Distribution rights of Foscavir)‘s full profile, request access.
Request a free trial